Structure Therapeutics' (GPCR) subsidiary Gasherbrum Bio signed a patent license agreement with Genentech, granting Genentech ...

くすりの大半は Gタンパク質共役型受容体（GPCR）注1） に作用して効果を発揮します。そのため、GPCRの活性化を効率的に測定することは、新たなくすりの開発への近道となります。今回、東北大学 大学院薬学研究科の青木 淳賢教授、井上 ...

Structure Therapeutics, Inc. Sponsored ADR ( ($GPCR) ) has issued an update. On December 30, 2025, Gasherbrum Bio, a subsidiary of Structure ...

－GPCRによるアレスチンの動的な活性化機構を解明－ 理化学研究所（理研）生命機能科学研究センター生体分子動的構造研究チームの嶋田一夫チームリーダー（次世代天然物化学技術組合技術顧問）、白石勇太郎研究員らの国際共同研究グループは ...

－既存のGPCR標的薬の限界を克服する新薬開発に期待－ 理化学研究所（理研）生命機能科学研究センター生体分子動的構造研究チームの嶋田一夫チームリーダー（次世代天然物化学技術研究組合技術顧問）、今井駿輔上級研究員、金子舜研修生らの共同研究 ...

G-protein coupled receptors (GPCRs) are proteins triggered by ligands (protein-binding chemicals) from outside cells to ...

Suntory Foundation for Life Sciences, Bioorganic Research Institute, Osaka, Japan A G protein-coupled receptor (GPCR) functions not only as a monomer or homodimer but also as a heterodimer with ...

Expressions of G protein-coupled receptors (GPCR) on immune and tissue resident cells are the consequence of the cellular environment, which is highly variable. As discussed here, antibodies directed ...

G Protein-Coupled Receptors (GPCRs) are vital players in cellular signalling and key targets for drug discovery, especially within the GPCR-A17 subfamily, which is linked to various diseases. To ...

Global g-protein coupled receptors (GPCRs) market growth is Driven by Rising drug discovery activities, expanding applications in targeted therapeutics, and increasing prevalence of chronic and ...